TCTR20161008001招募中未知
Comparison of efficacy and safety of 0.01% Bimatoprost and 0.1%Tacrolimus in the treatment of facial vitiligo
Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital0 个研究点目标入组 40 人开始时间: 2016年10月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 Years 至 90 Years(—)
- 性别
- All
入选标准
- •- facial vitiligo patient
- •- other affected vitiligo area less than 2% BSA
排除标准
- •- apply topical steroid within 7 days
- •- on current medication effected skin pigmentation within 2 weeks
- •- on current treatment of vitiligo such as oral medication, NBVUB, PUVA, systemic steriod within 1 month
- •- allergy to bimatoprost and protopic
- •- pregnancy and breast feeding patient
- •- underlying disease: asthma
研究者
相似试验
已完成
3 期
Efficacy and safety of bimatoprost 0.01% for the treatment of eyebrow hypotrichosis: A randomized, double-blind, vehicle-controlled studyEyebrow hypotrichosisMadarosisTCTR20160911001Division of Dermatology, Ramathibodi Hospital, Mahidol University40
尚未招募
不适用
Benefits and safety of bimatoprost solution in small white patch on skin and comparison of its effect with that of tacrolimusCTRI/2021/03/031699INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES
进行中(未招募)
不适用
Comparison between the effects on ocular pressure of Bimatoprost 0.01% and Timolol 0.5% during the day and nightglaucoma and ocular hypertensionMedDRA version: 14.1Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersEUCTR2010-024272-26-ITIRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS
招募中
2 期
Evaluation of efficacy of combined topical Bimatoprost and Fractionated carbon dioxide laser versus Bimatoprost alone in treatment of alopecia areataAlopecia areataIRCT20210715051895N1Kerman University of Medical Sciences20
尚未招募
不适用
A study to compare effectiveness and tolerability of Bimatoprost and Timolol eye drops in Open Angle Glaucoma.CTRI/2022/07/044079Dr Sreyanwita Mukherjee
